Richard M. Toselli - 21 Jun 2021 Form 4 Insider Report for INVIVO THERAPEUTICS HOLDINGS CORP.

Role: Officer, Director
Signature: /s/ Richard M. Toselli
Issuer symbol: N/A
Transactions as of: 21 Jun 2021
Net transactions value: -$15.54
Form type: 4
Filing time: 23 Jun 2021, 20:52:15 UTC
Next filing: 23 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVIV	Common Stock	Tax liability	$15.54	-21	-0.34%	$0.7400	6,217	21 Jun 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligationsapplicable to the vesting of 50 stock-settled restricted stock units ("RSUs"). The vesting schedule for the RSUs was amended on June 11, 2019, and the remaining shares underlying theunvested RSUs vest in equal semi-annual installments on June 18 and December 18 until fully vested on December 18, 2021.

Content

Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligationsapplicable to the vesting of 50 stock-settled restricted stock units ("RSUs"). The vesting schedule for the RSUs was amended on June 11, 2019, and the remaining shares underlying theunvested RSUs vest in equal semi-annual installments on June 18 and December 18 until fully vested on December 18, 2021.